These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2783373)

  • 1. Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemia.
    Urba WJ; Baseler MW; Kopp WC; Steis RG; Clark JW; Smith JW; Coggin DL; Longo DL
    Blood; 1989 Jan; 73(1):38-46. PubMed ID: 2783373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin.
    Thaler J; Denz H; Dietze O; Gastl G; Ho AD; Gattringer C; Greil R; Lechleitner M; Huber C; Huber H
    Leuk Res; 1989; 13(5):377-83. PubMed ID: 2787447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
    J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to 2'-deoxycoformycin after failure of interferon-alpha in nonsplenectomized patients with hairy cell leukemia.
    Foon KA; Nakano GM; Koller CA; Longo DL; Steis RG
    Blood; 1986 Jul; 68(1):297-300. PubMed ID: 3487358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
    Seymour JF; Talpaz M; Kurzrock R
    Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF).
    Spiers AS; Parekh SJ
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppressive effects of pentostatin.
    Kraut EH; Neff JC; Bouroncle BA; Gochnour D; Grever MR
    J Clin Oncol; 1990 May; 8(5):848-55. PubMed ID: 2332771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid response to 2'-deoxycoformycin in advanced hairy cell leukemia after failure of interferons alpha and gamma.
    Lembersky BC; Ratain MJ; Westbrook C; Golomb HM
    Am J Hematol; 1988 Jan; 27(1):60-2. PubMed ID: 3128105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
    Ho AD; Kuse R; Prümmer O; Porzsolt F; Hunstein W
    Klin Wochenschr; 1987 Oct; 65(20):975-9. PubMed ID: 3501501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of 2'-deoxycoformycin treatment on cytokine production in patients with hairy cell leukemia.
    Ho AD; Männel DN; Wulf G; Kirchner H; Gundt A; Trede I; Rensch K; Hunstein W
    Leukemia; 1990 Aug; 4(8):584-9. PubMed ID: 1697012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
    Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
    Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of hairy-cell leukaemia with 2'-deoxycoformycin.
    Johnston JB; Glazer RI; Pugh L; Israels LG
    Br J Haematol; 1986 Jul; 63(3):525-34. PubMed ID: 3488071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxycoformycin in therapy of refractory lymphoid neoplasms.
    Ho AD; Thaler J; Kuse R; Willemze R; Mandelli F; Lauria F; Zittoun R; Stryckmans P
    Onkologie; 1988 Feb; 11(1):35-7. PubMed ID: 3283623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials in hairy cell leukemia. Current status and future directions.
    Cheson BD; Martin A
    Ann Intern Med; 1987 Jun; 106(6):871-8. PubMed ID: 3555204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood and bone marrow changes following 2'-deoxycoformycin therapy in hairy cell leukemia. Results of 200 weeks' follow-up.
    Dalal BI; Freier L; Johnston JB; Merry CC; Israels LG
    Cancer; 1989 Jan; 63(1):14-22. PubMed ID: 2783375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hairy cell leukemia: the Ohio State University experience with deoxycoformycin.
    Bouroncle BA; Grever MR; Kraut EH
    Leukemia; 1987 Apr; 1(4):350-4. PubMed ID: 3499542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of hairy cell leukemia with 2'-deoxycoformycin: results in India and in the United States.
    Spiers AS; Parekh SJ
    Leukemia; 1987 Apr; 1(4):347-50. PubMed ID: 3499541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapy.
    Ho AD; Grossmann M; Knauf W; Martin H; Trümper L; Zwingers T; Sonnen R; Pralle H; Hunstein W
    Leukemia; 1989 Oct; 3(10):718-23. PubMed ID: 2506398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin).
    Spiers AS; Moore D; Cassileth PA; Harrington DP; Cummings FJ; Neiman RS; Bennett JM; O'Connell MJ
    N Engl J Med; 1987 Apr; 316(14):825-30. PubMed ID: 2434850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of 2'-deoxycoformycin in hairy-cell leukemia: a study of the National Cancer Institute of Canada Clinical Trials Group.
    Johnston JB; Eisenhauer E; Corbett WE; Scott JG; Zaentz SD
    J Natl Cancer Inst; 1988 Jul; 80(10):765-9. PubMed ID: 3290498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.